Association of APOA5 rs3135506 and CETP rs708272 Polymorphisms with Metabolic Syndrome in a Moroccan Population
Hamid Farhane, Fatima-Ezzahra Anaibar, Majida Motrane, Soufiane Karchali, Oumaima El Alaoui El Abdallaoui, Aïcha Motrane, Said Nassor Abeid, Abderraouf Hilali, Nourdin HarichBackground:
Metabolic syndrome (MetS) is a multifactorial condition and a major public health concern due to its strong association with cardiovascular disease and type 2 diabetes. Genetic factors contribute to its development. This study aims to evaluate the association between polymorphisms in genes APOA5 and CETP and susceptibility to MetS and its components in a Moroccan population.
Methods:
A case–control study was conducted, including 136 MetS patients and 138 controls recruited from the Doukkala region (Morocco). The APOA5 rs3135506 (C>G) and CETP rs708272 (G>A) polymorphisms were genotyped using PCR-RFLP.
Results:
The APOA5 rs3135506 polymorphism was significantly associated with increased MetS risk. The CG and GG genotypes conferred 2.39-fold (OR = 2.39;
Conclusion:
The APOA5 rs3135506 and CETP rs708272 polymorphisms may contribute to MetS susceptibility in the Moroccan population, with certain combined genotypes associated with increased risk. These findings support their potential as genetic biomarkers for early risk assessment but require confirmation in larger studies.